Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Merrimack Pharmaceuticals Inc (MACK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 78,439
  • Shares Outstanding, K 13,343
  • Annual Sales, $ 0 K
  • Annual Income, $ 472,030 K
  • 36-Month Beta 2.49
  • Price/Sales 0.54
  • Price/Cash Flow N/A
  • Price/Book 1.17

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Sell
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -1.01
  • Number of Estimates 1
  • High Estimate -1.01
  • Low Estimate -1.01
  • Prior Year -0.89
  • Growth Rate Est. (year over year) -13.48%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.77 +22.85%
on 01/16/19
6.25 -6.24%
on 02/06/19
+1.04 (+21.58%)
since 01/15/19
3-Month
3.70 +58.38%
on 12/20/18
6.25 -6.24%
on 02/06/19
+1.30 (+28.51%)
since 11/15/18
52-Week
3.34 +75.45%
on 10/19/18
11.70 -49.91%
on 03/09/18
-4.88 (-45.44%)
since 02/15/18

Most Recent Stories

More News
Shares of MACK Up 19.8% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Merrimack Pharma (NASDAQ:MACK) on January 11th, 2019 at $4.97. In approximately 1 month, Merrimack Pharma has returned 19.84% as of today's recent price of $5.95.

MACK : 5.86 (-0.34%)
Merrimack (MACK) Stock Up Year to Date: Is a Rebound Likely?

Merrimack (MACK) regains its status as a development-stage biopharma company after the sale of its sole marketed product Onivyde in 2017.

LGND : 120.86 (-0.02%)
CELG : 90.69 (+0.01%)
ADRO : 4.05 (+10.05%)
MACK : 5.86 (-0.34%)
Uptrend Call Working As Merrimack Pharma Stock Rises 15.8% (MACK)

SmarTrend identified an Uptrend for Merrimack Pharma (NASDAQ:MACK) on January 11th, 2019 at $4.97. In approximately 3 weeks, Merrimack Pharma has returned 15.81% as of today's recent price of $5.75.

MACK : 5.86 (-0.34%)
John M. Dineen Appointed to Syneos Health Board of Directors, Named Chairman

Syneos Health(TM) (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that John M. Dineen has been appointed to the Company's Board of Directors and named...

SYNH : 54.74 (+1.60%)
CTSH : 73.56 (+0.60%)
MACK : 5.86 (-0.34%)
Merrimack (MACK) Down 7.5% Since Last Earnings Report: Can It Rebound?

Merrimack (MACK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

MACK : 5.86 (-0.34%)
Merrimack (MACK) Suffers Wider-Than-Expected Loss in Q3

Merrimack (MACK) discourages with Q3 loss, falling shy of estimates as well as deteriorates from the year-ago quarter's figure. Also, the company fails to reap any revenues in the period.

AZN : 40.92 (+2.35%)
SHPG : 179.20 (+4.10%)
SNY : 42.55 (+2.38%)
MACK : 5.86 (-0.34%)
Research Report Identifies Merrimack Pharmaceuticals, PNM Resources, Inc. (Holding Co.), Carrols Restaurant Group, American Axle & Manufacturing, CBIZ, and Nova Measuring Instruments with Renewed Outlook -- Fundamental Analysis, Calculating Forward Movement

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Merrimack Pharmaceuticals,...

NVMI : 24.93 (+1.26%)
AXL : 16.83 (+14.49%)
TAST : 9.29 (+2.65%)
CBZ : 20.99 (+2.74%)
PNM : 43.36 (+0.70%)
MACK : 5.86 (-0.34%)
Merrimack Reports Third Quarter 2018 Financial Results and Provides Strategic Update Following Portfolio Review

Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK), a research and clinical development oncology company focused on biomarker-defined cancers, today announced its third quarter 2018 financial results for the...

MACK : 5.86 (-0.34%)
5 Drug/Biotech Stocks Set to Trump Estimates in Q3 Earnings

There are still a number of drug/biotech companies poised to surpass third-quarter estimates.

CRSP : 31.52 (+1.91%)
BDSI : 4.63 (+3.12%)
EDIT : 20.08 (+1.11%)
REGN : 423.97 (+2.17%)
MACK : 5.86 (-0.34%)
Merrimack Announces Timing of Third Quarter 2018 Investor Conference Call

Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) today announced that the company will host its third quarter 2018 investor conference call and webcast at 8:30 am ET on Wednesday, November 7, 2018.

MACK : 5.86 (-0.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade MACK with:

Business Summary

Merrimack Pharmaceuticals, Inc., is a biopharmaceutical company focused on the discovery, development and preparation to commercialize innovative medicines paired with companion diagnostics for the treatment of serious diseases, with a special focus on cancer. Merrimack Pharmaceuticals, Inc. is headquartered...

See More

Key Turning Points

2nd Resistance Point 6.03
1st Resistance Point 5.94
Last Price 5.86
1st Support Level 5.81
2nd Support Level 5.77

See More

52-Week High 11.70
Fibonacci 61.8% 8.51
Fibonacci 50% 7.52
Fibonacci 38.2% 6.53
Last Price 5.86
52-Week Low 3.34

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar